What is GENB's dilution risk score?

GENB has a latest available DilutionScore record of 44/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for GENB, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for GENB?

DilutionWatch tracks 25 SEC filing types for GENB including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect GENB shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For GENB, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for GENB tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for GENB. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

GENB Dilution Risk Score: 44/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

25

📊 Float Risk

40

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for GENB.

🔔 Track GENB — Get forecast alerts →

Market Data

Market Cap$1.68B

Shares Outstanding128.35M

Float60.29M

Cash$457.42M

DebtN/A

Short InterestN/A

Institutional Holdings

10 institutional holders · 85.75M shares

#1 Flagship Pioneering LLC 62.67M shares

#2 FMR, LLC 4.22M shares

#3 Capital World Investors 4.00M shares

+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.28M

Days to Cover15.2

% of Float12.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2026-03-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual GENB Dilution Snapshot

Generate Biomedicines, Inc. (GENB) has a DilutionScore of 44/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for GENB: xbrl on 2026-06-30; xbrl on 2026-03-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.